High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk.

ABSTRACT:

Background

Elevation of systemic inflammatory markers were found to correlate with increased disease extent, reduced lung function and higher risk of future severe exacerbations in patients with bronchiectasis. Although a significant correlation of circulating hs-CRP levels with HRCT scores and resting oxygen saturation in patients with stable-state non-cystic fibrosis (CF) bronchiectasis was suggested, there is little data on the relationship between hs-CRP and the prognosis of bronchiectasis and a lack of data on the role of hs-CRP in predicting bronchiectasis exacerbation.

Methods

A prospective study was conducted on Chinese patients with non- CF bronchiectasis from 1st October to 31st December 2021. Baseline serum hs-CRP were obtained at stable-state. The follow-up perio

SUBMITTER: Kwok WC 

PROVIDER: S-EPMC10863114 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature